Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
If you have accidentally taken a double dose, contact NHS 111 or your GP immediately for advice
NICE guidance recommends considering GLP-1 receptor agonists for patients with type 2 diabetes who have inadequate glycaemic control despite optimal oral therapy and who have a BMI 35 kg/m (or 32.5 kg/m in certain ethnic groups), or for whom insulin therapy would have significant occupational implications or weight loss would benefit other obesity-related comorbidities
Immunity and Seasonal Resilience Delhi winters, Mumbai monsoons, and Chennais coastal humidity each take a toll on immunity
Beginning in 2024, the FDA expanded Wegovys approval to include reducing cardiovascular risk in adults with existing heart disease
